Why Is Apogee Therapeutics Stock Trading Higher On Monday?

benzinga.com/general/biotech/25/05/45357154/why-is-apogee-therapeutics-stock-trading-higher-on-monday

Apogee Therapeutics, Inc. (NASDAQ:APGE) on Monday revealed interim data from its Phase 1b trial of APG808, a novel half-life extended IL-4Rα antibody, in patients with mild-to-moderate asthma.
The Phase 1b double-blind, placebo-controlled, multiple-dose trial evaluated the safety and…

This story appeared on benzinga.com, 2025-05-12 18:21:26.
The Entire Business World on a Single Page. Free to Use →